Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2008 1
2011 1
2012 3
2013 1
2014 1
2015 1
2017 1
2018 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
Tortorella C, Aiello A, Gasperini C, Agrati C, Castilletti C, Ruggieri S, Meschi S, Matusali G, Colavita F, Farroni C, Cuzzi G, Cimini E, Tartaglia E, Vanini V, Prosperini L, Haggiag S, Galgani S, Quartuccio ME, Salmi A, Repele F, Altera AMG, Cristofanelli F, D'Abramo A, Bevilacqua N, Corpolongo A, Puro V, Vaia F, Capobianchi MR, Ippolito G, Nicastri E, Goletti D; INMI COVID-19 Vaccine Study Group. Tortorella C, et al. Among authors: ippolito g, puro v. Neurology. 2022 Feb 1;98(5):e541-e554. doi: 10.1212/WNL.0000000000013108. Epub 2021 Nov 22. Neurology. 2022. PMID: 34810244 Free PMC article.
Local transmission of chikungunya in Rome and the Lazio region, Italy.
Vairo F, Mammone A, Lanini S, Nicastri E, Castilletti C, Carletti F, Puro V, Di Lallo D, Panella V, Varrenti D, Scaramozzino P, di Caro A, Scognamiglio P, Capobianchi MR, Ippolito G; Chikungunya Lazio Outbreak Group. Vairo F, et al. Among authors: ippolito g, puro v. PLoS One. 2018 Dec 21;13(12):e0208896. doi: 10.1371/journal.pone.0208896. eCollection 2018. PLoS One. 2018. PMID: 30576334 Free PMC article.
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study.
Lanini S, Scognamiglio P, Mecozzi A, Lombardozzi L, Vullo V, Angelico M, Gasbarrini A, Taliani G, Attili AF, Perno CF, De Santis A, Puro V, Cerqua F, D'Offizi G, Pellicelli A, Armignacco O, Mennini FS, Siciliano M, Girardi E, Panella V, Ippolito G; members of the Lazio Region HCV treatment group. Lanini S, et al. Among authors: ippolito g, puro v. BMC Infect Dis. 2018 May 16;18(1):223. doi: 10.1186/s12879-018-3125-6. BMC Infect Dis. 2018. PMID: 29769038 Free PMC article.
ALT temporal variation was assessed by mixed effect model mixed models with random intercept at patient's level and random slope at the level of the time; i.e. either before or after therapy. RESULTS: Between 30 December 2014 and 31 December 2016 5279 patients started a DA …
ALT temporal variation was assessed by mixed effect model mixed models with random intercept at patient's level and random slope at the leve …
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017.
Lanini S, Minosse C, Vairo F, Garbuglia A, Di Bari V, Agresta A, Rezza G, Puro V, Pendenza A, Loffredo MR, Scognamiglio P, Zumla A, Panella V, Ippolito G, Capobianchi MR; Gruppo Laziale Sorveglianza Epatiti Virali (GLaSEV). Lanini S, et al. Among authors: ippolito g, puro v. PLoS One. 2017 Nov 10;12(11):e0185428. doi: 10.1371/journal.pone.0185428. eCollection 2017. PLoS One. 2017. PMID: 29125835 Free PMC article.
Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy.
Lanini S, Garbuglia AR, Lapa D, Puro V, Navarra A, Pergola C, Ippolito G, Capobianchi MR. Lanini S, et al. Among authors: ippolito g, puro v. BMJ Open. 2015 Jul 14;5(7):e007110. doi: 10.1136/bmjopen-2014-007110. BMJ Open. 2015. PMID: 26173715 Free PMC article.
OBJECTIVES: The present study is aimed at describing the seroprevalence and exploring potential risk factor(s) for hepatitis E virus (HEV) in participants who voluntarily underwent anti-HIV antibody testing. ...
OBJECTIVES: The present study is aimed at describing the seroprevalence and exploring potential risk factor(s) for hepatitis E virus …
Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries.
Schilling S, Fusco FM, De Iaco G, Bannister B, Maltezou HC, Carson G, Gottschalk R, Brodt HR, Brouqui P, Puro V, Ippolito G; European Network for Highly Infectious Diseases project members. Schilling S, et al. Among authors: ippolito g, puro v. PLoS One. 2014 Oct 28;9(10):e100401. doi: 10.1371/journal.pone.0100401. eCollection 2014. PLoS One. 2014. PMID: 25350843 Free PMC article.
Another limitation of this study is the time elapsed between data collection and publication; e.g. in Germany one additional facility opened in the meantime. ...
Another limitation of this study is the time elapsed between data collection and publication; e.g. in Germany one additional facility …
Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries.
De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G; European Network for Highly Infectious Diseases Working Group. De Iaco G, et al. Among authors: ippolito g, puro v. Infect Control Hosp Epidemiol. 2012 Oct;33(10):1008-16. doi: 10.1086/667729. Epub 2012 Aug 27. Infect Control Hosp Epidemiol. 2012. PMID: 22961020
In 40 facilities, different levels of PPE are used according to a risk assessment process, and in 8 facilities, high-level PPE (e.g., positive-pressure complete suits or Trexler units) is always used. ...
In 40 facilities, different levels of PPE are used according to a risk assessment process, and in 8 facilities, high-level PPE (e.g., …
HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.
Mammone A, Pezzotti P, Angeletti C, Orchi N, Carboni A, Navarra A, Sciarrone MR, Sias C, Puro V, Guasticchi G, Ippolito G, Borgia P, Girardi E; SENDIH Study Group. Mammone A, et al. Among authors: ippolito g, puro v. BMC Infect Dis. 2012 Mar 20;12:65. doi: 10.1186/1471-2334-12-65. BMC Infect Dis. 2012. PMID: 22433313 Free PMC article.
These were classified with recent/non-recent infection on the basis of an avidity index result, or laboratory evidence of recently acquired infection (i.e., previous documented negative HIV test within 6 months; or presence of HIV RNA or p24 antigen with simultaneous negat …
These were classified with recent/non-recent infection on the basis of an avidity index result, or laboratory evidence of recently acquired …
Infection control management of patients with suspected highly infectious diseases in emergency departments: data from a survey in 41 facilities in 14 European countries.
Fusco FM, Schilling S, De Iaco G, Brodt HR, Brouqui P, Maltezou HC, Bannister B, Gottschalk R, Thomson G, Puro V, Ippolito G; EuroNHID Working Group. Fusco FM, et al. Among authors: ippolito g, puro v. BMC Infect Dis. 2012 Jan 28;12:27. doi: 10.1186/1471-2334-12-27. BMC Infect Dis. 2012. PMID: 22284435 Free PMC article.
BACKGROUND: In Emergency and Medical Admission Departments (EDs and MADs), prompt recognition and appropriate infection control management of patients with Highly Infectious Diseases (HIDs, e.g. Viral Hemorrhagic Fevers and SARS) are fundamental for avoiding nosocomial out …
BACKGROUND: In Emergency and Medical Admission Departments (EDs and MADs), prompt recognition and appropriate infection control management o …
15 results